Update on the Treatment of Trichotillomania

    November 2024 in “ Actas Dermo-Sifiliográficas ”
    L E Nina-Dominguez, Adrián Imbernón‐Moya, D Saceda-Corralo, Sérgio Vañó-Galván
    Trichotillomania (TTM) is a challenging obsessive-compulsive disorder characterized by recurrent hair pulling, leading to hair loss or alopecia. Effective management involves both pharmacological and non-pharmacological strategies. Cognitive-behavioral therapy is a successful treatment, though not all patients opt for it. Alternative support tools like electronic devices, internet therapies, and microneedling are suggested. N-acetylcysteine and memantine are recommended as first-line therapies due to their safety, efficacy, and minimal adverse effects. Other medications such as fluoxetine, clomipramine, olanzapine, and naltrexone show limited and variable efficacy. The review highlights current treatment options for TTM.
    Discuss this study in the Community →

    Related Community Posts Join

    3 / 3 results

      community C’est terrible - at my wits end

      in Female  445 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  146 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Similar Research

    5 / 1000+ results